Insider filing · BBIO
Charles J Homcy
Director
profile →
BridgeBio Pharma, Inc.
BBIO · Healthcare · 74 filings in 24 months
ticker →
Charles J Homcy sold $13.9M of BridgeBio Pharma (BBIO)
Executed Aug 8 2025, disclosed Aug 12 2025, 4 days later.
Value, as filed
$13.9M
300,000 sh across 3 lots
Executed
Aug 8 2025
the trade date, as filed
Disclosed
Aug 12 2025
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
CHCharles J Homcy (Director) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in BridgeBio Pharma, Inc. (BBIO). The largest single filing was $13.9M of BBIO (300,000 sh across 3 lots, as filed), executed Aug 8 2025.
The name
BBIOHealthcare · BridgeBio Pharma, Inc., a biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→